Careers  |  Sign In  |  Register

Rare Lung Disease Drug Gets FDA Approval

According to Reuters, the FDA has recently approved a drug by Pfizer to treat a rare lung disease most frequently found in women of childbearing age. The disease known as lymphangioleiomyomatosis (LAM) typically presents with symptoms similar to that of other lung conditions like emphysema or asthma but manifests in approximately 2-5 women per million. The drug, Rapamune, was formerly used to help prevent organ rejections but presently has been discovered and proven to slow the abnormal overgrowth of smooth muscle cells in lung tissue, the not cancerous but obstructive and dangerous effect of the disease.


Read the article published by Reuters.